Trademark Overview
On Monday, December 8, 2025, a trademark application was filed for AGILERA with the United States Patent and Trademark Office. The USPTO has given the AGILERA trademark a serial number of 99536140. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, December 8, 2025. This trademark is owned by Agilera Pharma AS. The AGILERA trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Transportation & Storage Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Distributorship services in the field of radiopharmaceuticals; distributorship services featuring pharmaceuticals, radiopharmaceuticals, and nuclear medicine products; business management and logistics management in the field of radiopharmaceuticals; supply chain management for pharmaceutical and radiopharmaceutical products; business administration and consulting services for radiopharmaceutical and radiopharmacy operations; Regulatory submission management services, namely, assisting others in preparing and filing applications for radiopharmaceuticals with governmental regulatory bodies
isotope production for medical, research, and commercial use; contract development and manufacturing services (CDMO) in the field of pharmaceuticals and radiopharmaceuticals; Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials; Manufacturing services in the field of pharmaceuticals and radiopharmaceuticals; Custom manufacture of pharmaceuticals
laboratory testing, quality control, and validation services for radiopharmaceuticals; process development, optimization, and scale-up services; technological consultancy relating to radiopharmaceutical production and regulatory compliance; Pharmaceutical drug development services; Laboratory services for the production of radiopharmaceuticals in the nature of research and development of new products and testing of pharmaceuticals; Quality control for others; Scientific and technological services and research in the field of radiochemistry, radiopharmaceuticals, and nuclear medicine
Supply chain and logistics services, namely, transportation, delivery, distribution, and storage of radiopharmaceuticals and radioisotopes; consultation and coordination services relating to the transport and storage of radiopharmaceuticals and radioisotopes
Radiopharmaceutical and radioisotope preparations for clinical, medical, diagnostic and therapeutic use